Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6238971 | Health Policy | 2016 | 16 Pages |
Abstract
The pricing and reimbursement policy landscape can be improved through higher drug quality standards, greater market concentration, an increase in government subsidies, quality-oriented tendering, wider implementation of the zero mark-up policy, through linking reimbursement with rational prescribing, and the promotion of health technology assessment and comparative effectiveness research. Addressing broader issues of regulatory fragmentation, the lack of transparency and corruption will help ensure that policies are created in a coherent, evidence-based fashion.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Jia Hu, Elias Mossialos,